B
Bicara Therapeutics Inc. Common Stock
BCAX · NASDAQ · Healthcare · 1.6B
Closing price
$17.50
+1.39% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
2.4×
Enterprise value / EBITDAEV/EBITDA
-6.3×
Free cash flow yieldFCF yield
-11.2%
Return on equityROE
-34.4%
Operating margin
—
Net debt / EBITDAbalance-sheet strength
0.7×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.